Skip to main content
Contact Us
Subscribe
E-Edition
95°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly And Co
Recent news which mentions Eli Lilly And Co
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
July 02, 2024
Tags
Biotech and Pharmaceuticals
Eli Lilly and Co
Health care industry
From
CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
July 01, 2024
Tags
ETF Edge
Investment strategy
Alnylam Pharmaceuticals Inc
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Health & Science
Gilead Sciences Inc
Healthy Returns
From
CNBC.com News
Jim Cramer's top picks for pet-centric stocks
June 25, 2024
Tags
Investing
Business News
U/S/ Markets
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
Eli Lilly and Co
Asia News
Asia: Top News and Analysis
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
June 21, 2024
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Markets
Europe News
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Novo Nordisk A/S
Labor economy
Biotech and Pharmaceuticals
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
US: News
Companies
Biotechnology
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
U/S/ Markets
Business News
Investing
From
CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
June 10, 2024
Tags
Eli Lilly and Co
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
June 07, 2024
Tickers
RH
Tags
U/S/ Markets
Business News
Investing
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Science
Healthy Returns
Health & Science
From
CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
June 06, 2024
Tags
Breaking News: Technology
Internet
Technology
From
CNBC.com News
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
June 05, 2024
Tags
Breaking News: Technology
Alphabet Inc
Eli Lilly and Co
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Personnel
Novo Nordisk A/S
Labor economy
From
CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Biotechnology
Companies
US: News
From
CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024
Tags
Zealand Pharma A/S
Exchange/traded funds
Eli Lilly and Co
From
CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
May 25, 2024
Tags
WW International Inc
Novo Nordisk A/S
Hospitals
From
CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
May 24, 2024
Tags
Pharmaceuticals
Business
Eli Lilly and Co
From
CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
May 23, 2024
Tags
Trump Media & Technology Group Corp
Market Outlook
Investment strategy
From
CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
May 23, 2024
Tags
Fusion Pharmaceuticals Inc
Health & Science
AstraZeneca PLC
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Health & Science
Uber Technologies Inc
Novo Nordisk A/S
From
CNBC.com News
Roche says weight loss drug shows promising results in early trial
May 16, 2024
Tags
Carmot Therapeutics Inc
Breaking news
Business
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health & Science
From
CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
May 14, 2024
Tags
Health care industry
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits
May 13, 2024
Tags
AI / Artificial Intelligence
Tesla Inc
Breaking News: Technology
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health & Science
From
CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
Tags
Science
Pharmaceuticals
Business
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.